Volume 7, Issue 2

June 2012

Special focus: Neuroendocrine tumors Part I

Issue Editor:

8 articles in this issue

New treatments of pancreatic neuroendocrine tumors: why using them? How to use them?
Eric Raymond
Philippe Ruszniewski
Editorial 05 June 2012 Pages: 91 - 92
Relevance of angiogenesis in neuroendocrine tumors
Alexandre Teulé
Oriol Casanovas
Review 17 May 2012 Pages: 93 - 98
New targeted agents in gastroenteropancreatic neuroendocrine tumors
Marta Benavent
Maria Jose de Miguel
Rocio Garcia-Carbonero
Review 15 May 2012 Pages: 99 - 106
Liver-directed therapies in liver metastases from neuroendocrine tumors of the gastrointestinal tract
Magaly Zappa
Mohamed Abdel-Rehim
Valérie Vilgrain
Review 22 May 2012 Pages: 107 - 116
Sunitinib in pancreatic neuroendocrine tumors
Eric Raymond
Pascal Hammel
Sandrine Faivre
Review 02 June 2012 Pages: 117 - 125
Imaging response in neuroendocrine tumors treated with targeted therapies: the experience of sunitinib
Sandrine Faivre
Maxime Ronot
Eric Raymond
Review 15 May 2012 Pages: 127 - 133
Expression of metastasis-associated protein 2 (MTA2) might predict proliferation in non-small cell lung cancer
Shu-Li Liu
Yang Han
Shun-Dong Dai
Original Research 15 May 2012 Pages: 135 - 143
Pazopanib therapy for cerebellar hemangioblastomas in von Hippel–Lindau disease
Betty Y. S. Kim
Eric Jonasch
Ian E. McCutcheon
Day-to-Day Practice 29 February 2012 Pages: 145 - 149

Search